US Patent 7589108 1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands

Patent 7589108 was granted and assigned to Wyeth on September, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Wyeth

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

75891080

Patent Inventor Names

Steven Edward Lenicek0

Ronald Charles Bernotas0

Date of Patent

September 15, 2009

Patent Application Number

112382460

Date Filed

September 29, 2005

Patent Primary Examiner

‌

Celia Chang

Patent abstract

The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7589108 1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API